APNW Stock Price, News & Analysis

Apeiron Capital Investment Corp. (APNW) is a blank check company established with the goal of executing a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. As a special purpose acquisition company (SPAC), Apeiron Capital Investment Corp. aims to leverage its management's expertise to identify and integrate promising business ventures.

The company, headed by CEO Dr. Joel Shulman, recently announced the termination of its Business Combination Agreement with GIO World Health, Ltd., effective August 14, 2023. This agreement was initially formed on March 8, 2023, and amended on May 10, 2023. The termination comes as a result of the company’s inability to finalize an initial business combination within the stipulated timeframe mandated by its Amended and Restated Certificate of Incorporation.

With the termination finalized, Apeiron Capital Investment Corp. intends to dissolve and liquidate, redeeming all outstanding shares of common stock included in the units issued to public stockholders during its initial public offering. The redemption price per share will reflect the aggregate funds in the company’s trust account, including interest, minus dissolution expenses. Shareholders are expected to receive their pro rata portion of the trust account proceeds within ten business days post-August 14, 2023.

The company’s sponsor has agreed to waive redemption rights concerning its founder shares from a private placement, and there will be no redemption rights or liquidating distributions for the company's warrants, which are set to expire worthless.

This procedural liquidation underscores Apeiron Capital Investment Corp.'s commitment to ensuring the equitable treatment of its public shareholders. The company's operations have been closely monitored by regulatory authorities, including the SEC, as it navigates this complex financial landscape.